Availability of Non-Exclusive, Exclusive License or Partially Exclusive Licensing of U.S. Patent Concerning Enzyme-Catalyzed Modifications of Macromolecules in Organic Solvents

Summary

Biogen has submitted a request to the U.S. Patent and Trademark Office for the licensing of its U.S. patent concerning enzyme-catalyzed modifications of macromolecules in organic solvents, which could potentially impact the development of new treatments for various diseases.